Literature DB >> 2058870

Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease.

D P Sandler1, F R Burr, C R Weinberg.   

Abstract

OBJECTIVE: To evaluate the risk for chronic renal disease associated with regular use of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs).
DESIGN: Multicenter case-control study. PATIENTS: Patients were 554 North Carolina residents (age range, 30 to 79 years) hospitalized between 1980 and 1982 with a discharge diagnosis indicating newly diagnosed chronic renal dysfunction and a serum creatinine level consistently at or above 130 mumol/L (1.5 mg/dL). Controls were 516 persons chosen randomly by telephone screening (if younger than 65 years of age) and from listings of Medicare recipients (if 65 years of age or older), frequency-matched to patients by age, race, sex, and proximity to study hospitals. MEASUREMENTS: Data on use of prescription NSAIDs and other analgesics before 1980, other risk factors, and potential confounders were obtained by telephone interviews. Patients were classified by frequency and duration of use; daily users were those who took an NSAID for at least 360 consecutive days. MAIN
RESULTS: A twofold risk for chronic renal disease was associated with previous daily use of NSAIDs (adjusted odds ratio, 2.1; 95% Cl, 1.1 to 4.1). Increased risk was predominantly limited to men older than 65 years, for whom the odds ratio for daily use was 10.0 (Cl, 1.2 to 82.7) after adjusting for use of other analgesics. In other age-sex groups, the risk associated with NSAID use tended to be increased among those with heart disease or other factors that might indicate compromised renal circulation. These findings did not result from confounding by known renal disease risk factors and were not readily explained by potential biases.
CONCLUSIONS: Regular use of NSAIDs may increase the risk for chronic kidney disease in some high-risk groups. With the recent over-the-counter availability and increasing popularity of NSAIDs, the possibility of an increased risk for chronic renal disease associated with their use may warrant further scrutiny.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2058870     DOI: 10.7326/0003-4819-115-3-165

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  39 in total

1.  Drug points: Acute renal failure induced by topical ketoprofen.

Authors:  T Krummel; Y Dimitrov; B Moulin; T Hannedouche
Journal:  BMJ       Date:  2000-01-08

2.  Key questions concerning paracetamol and NSAIDs for osteoarthritis.

Authors:  P Courtney; M Doherty
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

Review 3.  Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs.

Authors:  Paul Dieppe; Christopher Bartlett; Peter Davey; Lesley Doyal; Shah Ebrahim
Journal:  BMJ       Date:  2004-07-03

4.  Direct toxicity of nonsteroidal antiinflammatory drugs for renal medullary cells.

Authors:  G M Rocha; L F Michea; E M Peters; M Kirby; Y Xu; D R Ferguson; M B Burg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 5.  Tolerability of topical NSAIDs in the elderly: do they really convey a safety advantage?

Authors:  J M Evans; T M MacDonald
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

6.  Evaluating ethnic differences in the prescription of NSAIDs for chronic kidney disease: a cross-sectional survey of patients in general practice.

Authors:  Sally Hull; Rohini Mathur; Gavin Dreyer; Muhammad Magdi Yaqoob
Journal:  Br J Gen Pract       Date:  2014-07       Impact factor: 5.386

Review 7.  Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs.

Authors:  L B Barradell; R Whittington; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

Review 8.  Analgesic abuse in the elderly. Renal sequelae and management.

Authors:  M M Elseviers; M E De Broe
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

Review 9.  Management of acute and chronic gouty arthritis: present state-of-the-art.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Intravenous ketorolac vs diclofenac for analgesia after maxillofacial surgery.

Authors:  P Tarkkila; M Tuominen; P H Rosenberg
Journal:  Can J Anaesth       Date:  1996-03       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.